EUVIMEDEUVIMED entdecken
VergleichsstudieEvaluationsstudieOpen Access · CC BY 4.0

Evaluating 12 automated, whole-genome sequencing analysis pipelines for Mycobacterium tuberculosis complex: a comparative study

Ruan Spies, Derrick W Crook, Timothy E A Peto, Philip W Fowler, Robert Turner, Hieu Thai, James A Watson, Timothy M Walker

The Lancet Microbe · 2025

DOI: 10.1016/j.lanmic.2025.101210 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The Lancet Microbe, 2025. Verfasst von Ruan Spies und 7 weiteren Autor:innen. Beteiligte Einrichtung: Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Nuffield Department of Medicine, University of Oxford, Oxford, UK. Electronic a…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Whole Genome Sequencing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Rhodes Trust, National Health Service Corps.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Reliance on complex, custom-built bioinformatics pipelines is a barrier to the implementation of whole-genome sequencing (WGS) of Mycobacterium tuberculosis in high-burden settings in some low-income and middle-income countries (LMICs). Automated analysis pipelines could address this inequity in access to WGS-based diagnostics and surveillance. This study aimed to systematically evaluate the performance and usability of publicly available WGS pipelines for M tuberculosis. METHODS: We identified automated M tuberculosis WGS analysis pipelines through searches of PubMed and GitHub from database inception up to Aug 31, 2024. Accuracy, cost, accessibility, and scalability were assessed for each pipeline. We evaluated the accuracy of genotypic drug susceptibility testing (gDST) using publicly available sequences with phenotypic susceptibility data for 12 antituberculosis drugs. We estimated pooled sensitivity and specificity for each pipeline, across all drugs, by conducting a bivariate meta-analysis, with random effects representing between-drug variability. Lineage classifications were compared, and a previously epidemiologically well-characterised dataset was used to compare measures of genomic relatedness. FINDINGS: Among 28 candidate pipelines, 16 were excluded as they were unmaintained and inexecutable. 12 pipelines (11 compatible with Illumina and four compatible with Nanopore), all free to use, were included for evaluation. Six pipelines processed and stored data remotely, but for five of these six, scalability was limited by the need to upload sequences through web portals. For local processing pipelines, scalability was dependent on substantial local computational resources, data storage capacity, and command-line interfaces that limited user-friendliness. Only one of six remote-processing pipelines removed human DNA sequences before server upload. gDST was similarly accurate across ten of 11 Illumina-compatible pipelines and three of four Nanopore-compatible pipelines. All pipelines classified the main lineages consistently, although there were differences at sublineage resolution. Outputs from three of four pipelines reporting genomic relatedness were compatible with commonly cited single nucleotide polymorphism difference thresholds. INTERPRETATION: Numerous automated analysis pipelines capable of enhancing equity in M tuberculosis WGS are available. Given the overall similarities between the pipelines evaluated in this study in terms of gDST performance, lineage classification, and genomic relatedness inference, non-functional attributes such as availability, accessibility, scalability, and privacy could represent the point of difference for prospective users in LMICs with a high burden of tuberculosis. FUNDING: The Rhodes Trust, Wellcome, Ellison Institute of Technology, and the UK National Institute for Health and Care Research Oxford Biomedical Research Centre.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisWhole Genome SequencingHumansGenome, BacterialAntitubercular AgentsMicrobial Sensitivity TestsComputational BiologyGenotypeTuberculosisSensitivity and Specificity

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Nuffield Department of Medicine, University of Oxford, Oxford, UK. Electronic address: rspies@oucru.org.
  • Nuffield Department of Medicine, University of Oxford, Oxford, UK; National Institute of Health Research Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK; Health Protection Research Unit in Healthc…
  • Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Förderung

  • Wellcome Trust
  • Rhodes Trust
  • National Health Service Corps
  • National Institute for Health Research Health Protection Research Unit
  • National Institute for Health and Care Research
  • NIHR Oxford Biomedical Research Centre

Zitieren

APA

Spies, R., Crook, D. W., Peto, T. E. A., Fowler, P. W., Turner, R., Thai, H., Watson, J. A., & Walker, T. M. (2025). Evaluating 12 automated, whole-genome sequencing analysis pipelines for Mycobacterium tuberculosis complex: a comparative study. The Lancet Microbe. https://doi.org/10.1016/j.lanmic.2025.101210

Vancouver

Spies R, Crook DW, Peto TEA, Fowler PW, Turner R, Thai H, et al. Evaluating 12 automated, whole-genome sequencing analysis pipelines for Mycobacterium tuberculosis complex: a comparative study. The Lancet Microbe. 2025. doi:10.1016/j.lanmic.2025.101210

BibTeX
@article{Spies2025,
  author = {Spies, Ruan and Crook, Derrick W and Peto, Timothy E A and Fowler, Philip W and Turner, Robert and Thai, Hieu and Watson, James A and Walker, Timothy M},
  title = {Evaluating 12 automated, whole-genome sequencing analysis pipelines for Mycobacterium tuberculosis complex: a comparative study},
  journal = {The Lancet Microbe},
  year = {2025},
  doi = {10.1016/j.lanmic.2025.101210}
}
Kostenlos starten →